MYERS ROBERT L 4
4 · Predictive Oncology Inc. · Filed Sep 24, 2021
Insider Transaction Report
Form 4
MYERS ROBERT L
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock, $.01 par value
2021-09-23$1.13/sh+33,334$37,667→ 33,411 total - Exercise/Conversion
Restricted Stock Units
2021-09-23−33,334→ 66,666 total→ Common Stock (33,334 underlying) - Disposition to Issuer
Common Stock, $.01 par value
2021-09-23$1.13/sh−10,200$11,526→ 23,211 total
Footnotes (3)
- [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
- [F2]On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments beginning on the first anniversary of the grant date. The first of these installments vests on September 23, 2021. The remainder vests on each of 9/23/2022 and 9/23/2023.
- [F3]10,200 shares of common stock forfeited to Company on September 23, 2021 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.